- Report
- July 2026
- 200 Pages
Global
From €7260EUR$7,990USD£6,240GBP
- Report
- July 2026
- 203 Pages
Global
From €7260EUR$7,990USD£6,240GBP
- Report
- July 2026
- 160 Pages
Global
From €7260EUR$7,990USD£6,240GBP
- Report
- July 2026
- 191 Pages
Global
From €7260EUR$7,990USD£6,240GBP
- Report
- July 2026
- 123 Pages
Global
From €7260EUR$7,990USD£6,240GBP
- Report
- July 2026
- 216 Pages
Global
From €7260EUR$7,990USD£6,240GBP
- Report
- May 2026
- 30 Pages
Global
From €2499EUR$2,750USD£2,148GBP
- Report
- May 2026
- 30 Pages
Global
From €2499EUR$2,750USD£2,148GBP
- Report
- May 2026
- 30 Pages
Global
From €2499EUR$2,750USD£2,148GBP
- Report
- May 2026
- 30 Pages
Global
From €2499EUR$2,750USD£2,148GBP
- Report
- May 2026
- 30 Pages
Global
From €2499EUR$2,750USD£2,148GBP
- Report
- May 2026
- 30 Pages
Global
From €2499EUR$2,750USD£2,148GBP
- Report
- May 2026
- 30 Pages
Global
From €2499EUR$2,750USD£2,148GBP
- Clinical Trials
- May 2026
- 280 Pages
Global
From €2726EUR$3,000USD£2,343GBP
- Report
- May 2026
- 30 Pages
Global
From €2499EUR$2,750USD£2,148GBP
- Report
- May 2026
- 30 Pages
Global
From €2499EUR$2,750USD£2,148GBP
- Drug Pipelines
- April 2026
- 60 Pages
Global
From €1363EUR$1,500USD£1,171GBP
- Clinical Trials
- April 2026
- 180 Pages
Global
From €2272EUR$2,500USD£1,952GBP
- Report
- April 2026
- 30 Pages
Global
From €2499EUR$2,750USD£2,148GBP
- Report
- March 2026
- 30 Pages
Global
From €2499EUR$2,750USD£2,148GBP

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics.
The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more